Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation
Copyright © 2021 by the American Society of Nephrology..
BACKGROUND AND OBJECTIVES: In contrast to shigatoxin-associated Escherichia coli (STEC) causing hemolytic uremic syndrome, STEC-unrelated infections associated with thrombotic microangiopathy are less characterized.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our retrospective study in a four-hospital institution of 530 consecutive patients with adjudicated thrombotic microangiopathies during the 2009-2016 period studied STEC-unrelated infections' epidemiology and major outcomes (death, acute dialysis, and major cardiovascular events).
RESULTS: STEC-unrelated infection was present in 145 of 530 (27%) patients, thrombotic microangiopathies without infection were present in 350 of 530 (66%) patients, and STEC causing hemolytic and uremic syndrome was present in 35 of 530 (7%) patients. They (versus thrombotic microangiopathy without infection) were associated with age >60 years (36% versus 18%), men (53% versus 27%), altered consciousness (32% versus 11%), mean BP <65 mm Hg (21% versus 4%), lower hemoglobin and platelet count, and AKI (72% versus 49%). They were associated with more than one pathogen in 36 of 145 (25%) patients (either isolated [14%] or combined [86%] to other causes of thrombotic microangiopathy); however, no significant clinical or biologic differences were noted between the two groups. They were more frequently due to bacteria (enterobacteria [41%], Staphylococcus aureus [11%], and Streptococcus pneumonia [3%]) than viruses (Epstein-Barr [20%], cytomegalovirus [18%], influenza [3%], hepatitis C [1%], HIV [1%], and rotavirus [1%]). STEC-unrelated infections were independent risk factors for in-hospital death (odds ratio, 2.22; 95% confidence interval, 1.18 to 4.29), major cardiovascular event (odds ratio, 3.43; 95% confidence interval, 1.82 to 6.69), and acute dialysis (odds ratio, 3.48; 95% confidence interval, 1.78 to 7.03). Bacteria (versus other pathogens), and among bacteria, enterobacteria, presence of more than one bacteria, and E. coli without shigatoxin were risk factors for acute dialysis.
CONCLUSIONS: Infections are frequent thrombotic microangiopathy triggers or causes, and they are mostly unrelated to STEC. Infections convey a higher risk of death and major complications. The most frequent pathogens were enterobacteria, S. aureus, Epstein-Barr virus, and cytomegalovirus.
PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2021_09_07_CJN17511120.mp3.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Clinical journal of the American Society of Nephrology : CJASN - 16(2021), 9 vom: 08. Sept., Seite 1355-1364 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Thoreau, Benjamin [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 31.01.2022 Date Revised 21.04.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2215/CJN.17511120 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330393928 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330393928 | ||
| 003 | DE-627 | ||
| 005 | 20231225211207.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2215/CJN.17511120 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1101.xml |
| 035 | |a (DE-627)NLM330393928 | ||
| 035 | |a (NLM)34497111 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Thoreau, Benjamin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.01.2022 | ||
| 500 | |a Date Revised 21.04.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 by the American Society of Nephrology. | ||
| 520 | |a BACKGROUND AND OBJECTIVES: In contrast to shigatoxin-associated Escherichia coli (STEC) causing hemolytic uremic syndrome, STEC-unrelated infections associated with thrombotic microangiopathy are less characterized | ||
| 520 | |a DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Our retrospective study in a four-hospital institution of 530 consecutive patients with adjudicated thrombotic microangiopathies during the 2009-2016 period studied STEC-unrelated infections' epidemiology and major outcomes (death, acute dialysis, and major cardiovascular events) | ||
| 520 | |a RESULTS: STEC-unrelated infection was present in 145 of 530 (27%) patients, thrombotic microangiopathies without infection were present in 350 of 530 (66%) patients, and STEC causing hemolytic and uremic syndrome was present in 35 of 530 (7%) patients. They (versus thrombotic microangiopathy without infection) were associated with age >60 years (36% versus 18%), men (53% versus 27%), altered consciousness (32% versus 11%), mean BP <65 mm Hg (21% versus 4%), lower hemoglobin and platelet count, and AKI (72% versus 49%). They were associated with more than one pathogen in 36 of 145 (25%) patients (either isolated [14%] or combined [86%] to other causes of thrombotic microangiopathy); however, no significant clinical or biologic differences were noted between the two groups. They were more frequently due to bacteria (enterobacteria [41%], Staphylococcus aureus [11%], and Streptococcus pneumonia [3%]) than viruses (Epstein-Barr [20%], cytomegalovirus [18%], influenza [3%], hepatitis C [1%], HIV [1%], and rotavirus [1%]). STEC-unrelated infections were independent risk factors for in-hospital death (odds ratio, 2.22; 95% confidence interval, 1.18 to 4.29), major cardiovascular event (odds ratio, 3.43; 95% confidence interval, 1.82 to 6.69), and acute dialysis (odds ratio, 3.48; 95% confidence interval, 1.78 to 7.03). Bacteria (versus other pathogens), and among bacteria, enterobacteria, presence of more than one bacteria, and E. coli without shigatoxin were risk factors for acute dialysis | ||
| 520 | |a CONCLUSIONS: Infections are frequent thrombotic microangiopathy triggers or causes, and they are mostly unrelated to STEC. Infections convey a higher risk of death and major complications. The most frequent pathogens were enterobacteria, S. aureus, Epstein-Barr virus, and cytomegalovirus | ||
| 520 | |a PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2021_09_07_CJN17511120.mp3 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a acute kidney injury | |
| 650 | 4 | |a clinical epidemiology | |
| 650 | 4 | |a clinical nephrology | |
| 650 | 4 | |a cytomegalovirus | |
| 650 | 4 | |a epidemiology and outcomes | |
| 650 | 4 | |a hemolytic uremic syndrome | |
| 650 | 4 | |a infections | |
| 650 | 4 | |a thrombotic microangiopathies | |
| 700 | 1 | |a von Tokarski, Florent |e verfasserin |4 aut | |
| 700 | 1 | |a Bauvois, Adeline |e verfasserin |4 aut | |
| 700 | 1 | |a Bayer, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Barbet, Christelle |e verfasserin |4 aut | |
| 700 | 1 | |a Cloarec, Sylvie |e verfasserin |4 aut | |
| 700 | 1 | |a Mérieau, Elodie |e verfasserin |4 aut | |
| 700 | 1 | |a Lachot, Sébastien |e verfasserin |4 aut | |
| 700 | 1 | |a Garot, Denis |e verfasserin |4 aut | |
| 700 | 1 | |a Bernard, Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Gyan, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Perrotin, Franck |e verfasserin |4 aut | |
| 700 | 1 | |a Pouplard, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Maillot, François |e verfasserin |4 aut | |
| 700 | 1 | |a Gatault, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Sautenet, Bénédicte |e verfasserin |4 aut | |
| 700 | 1 | |a Rusch, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Frémeaux-Bacchi, Véronique |e verfasserin |4 aut | |
| 700 | 1 | |a Vigneau, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Fakhouri, Fadi |e verfasserin |4 aut | |
| 700 | 1 | |a Halimi, Jean-Michel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical journal of the American Society of Nephrology : CJASN |d 2006 |g 16(2021), 9 vom: 08. Sept., Seite 1355-1364 |w (DE-627)NLM172123720 |x 1555-905X |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2021 |g number:9 |g day:08 |g month:09 |g pages:1355-1364 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2215/CJN.17511120 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2021 |e 9 |b 08 |c 09 |h 1355-1364 | ||